Promoting Surgical Resection through Future Liver Remnant Hypertrophy.
Pouya EntezariBeau B ToskichEdward KimSiddharth A PadiaDerrick ChristopherAlex SherBartley ThornburgElias S HohlastosRiad SalemJeremy C CollinsRobert J LewandowskiPublished in: Radiographics : a review publication of the Radiological Society of North America, Inc (2022)
An inadequate future liver remnant (FLR) can preclude curative-intent surgical resection for patients with primary or secondary hepatic malignancies. For patients with normal baseline liver function and without risk factors, an FLR of 20% is needed to maintain postsurgical hepatic function. However, the FLR requirement is higher for patients who are exposed to systemic chemotherapy (FLR, >30%) or have cirrhosis (FLR, >40%). Interventional radiologic and surgical methods to achieve FLR hypertrophy are evolving, including portal vein ligation, portal vein embolization, radiation lobectomy, hepatic venous deprivation, and associating liver partition and portal vein ligation for staged hepatectomy. Each technique offers particular advantages and disadvantages. Knowledge of these procedures can help clinicians to choose the suitable technique for each patient. The authors review the techniques used to develop FLR hypertrophy, focusing on technical considerations, outcomes, and the advantages and disadvantages of each approach. Online supplemental material is available for this article. © RSNA, 2022.
Keyphrases
- risk factors
- end stage renal disease
- prognostic factors
- healthcare
- newly diagnosed
- ejection fraction
- chronic kidney disease
- current status
- metabolic syndrome
- palliative care
- type diabetes
- peritoneal dialysis
- social media
- case report
- adipose tissue
- health information
- weight loss
- radiation induced
- patient reported outcomes
- patient reported